USA flag logo/image

An Official Website of the United States Government

Dialysis Disinfectant Replacing Formaldehyde, Sterilants

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
22186
Program Year/Program:
1994 / SBIR
Agency Tracking Number:
22186
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
BIOMEDICAL DEVELOPMENT CORPORATION
A152 ASTeCC Building Lexington, KY 40506-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1994
Title: Dialysis Disinfectant Replacing Formaldehyde, Sterilants
Agency: HHS
Contract: N/A
Award Amount: $600,000.00
 

Abstract:

Formaldehyde is a common disinfecting agent in dialyzer membrane reuse procedures. Since formaldehyde is carcinogenic, toxic and malodorous, any safe, cost-effective alternative would be a marketable an medical success. The long-term objective is to benefit patient care, employee safety, and cost effectiveness by establishing an economically competitive, non-toxic, market alternative to formaldehyde. The short-term objective is to test the effectiveness of a new cost-effective cold disinfectant technology for dialysis membranes following human use. A secondary objective is to evaluate the effect of this disinfecting process on maintaining fiber bundle volume (FBV). A clinically relevant Phase I study evaluating the effect of the cold disinfecting agent on dialyzer membranes will be performed. Biocidal effectiveness will be determined by culturing the dialyzer membranes following a typical 72-hour storage. A second in vitro protocol to evaluate FBV will also be done using dialysis membranes and plasma. The FBV data will be compared to previously obtained data from our unit as well as published observations on maintaining FBV. These protocols should provide relevant and sufficient data to thoroughly evaluate this cold sterilant and, if successful, provide sufficient preliminary work to substantiate a Phase II study.

Principal Investigator:

Richard W. Osgood
5123423898

Business Contact:

Small Business Information at Submission:

Biomedical Development
P. O. Box 6445 San Antonio, TX 78209

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No